Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
37.82
-2.36 (-5.87%)
At close: Jul 28, 2026, 4:00 PM EDT
37.82
0.00 (0.00%)
After-hours: Jul 28, 2026, 4:10 PM EDT

Nanobiotix Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Nanobiotix stock has a consensus rating of "Strong Buy" and an average price target of $44.38. The average 1-year stock price forecast is 17.35% higher than the current stock price, while the lowest is $29.11 (-23.03%) and the highest is $68.76 (+81.81%).

Price Target: $44.38 (+17.35%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$29.11$44.38$35.28$68.76
Change-23.03%+17.35%-6.72%+81.81%
* Price targets were last updated on Jun 4, 2026.

Analyst Ratings

The average analyst rating for Nanobiotix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy566555
Buy000100
Hold000022
Sell000000
Strong Sell000000
Total566677

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Hold
Maintains
$30
HoldMaintains$30-20.68%Jun 4, 2026
Guggenheim
Guggenheim
Buy
Reiterates
$36
BuyReiterates$36-4.81%May 5, 2026
TD Cowen
TD Cowen
Buy
Maintains
n/a
BuyMaintainsn/an/aApr 1, 2026
Leerink Partners
Leerink Partners
Buy
Maintains
$26$37
BuyMaintains$26$37-2.17%Apr 1, 2026

Financial Forecast

Revenue This Year
38.06M
from 32.59M
Increased by 16.78%
Revenue Next Year
42.83M
from 38.06M
Increased by 12.52%
EPS This Year
-0.30
from -0.50
EPS Next Year
-0.24
from -0.30
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
2.65M4.78M36.21M-7.19M32.59M38.06M
Revenue Growth
13.85%80.43%658.10%--16.78%
Gross Profit
2.65M4.78M36.21M-7.19M32.59M34.64M
Gross Margin
100.00%100.00%100.00%100.00%100.00%91.00%
Operating Income
-47.17M-45.72M-24.24M-68.26M-10.88M-7.68M
Net Income
-47.00M-57.04M-39.70M-68.13M-23.96M-12.18M
EPS
-----0.50-0.30
Free Cash Flow
-13.94M-24.74M-5.35M-33.16M-7.89M-23.80M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High66.2M
Avg38.1M
Low10.0M

Revenue Growth

Revenue Growth202620272028
High
103.0%
Avg
16.8%
Low
-69.3%

EPS Forecast

EPS202620272028
High0.32
Avg-0.30
Low-0.91

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-